Global Closed System Transfer Device Market to Reach USD 4,358.25 Million by 2032 | CAGR of 14.4%
Category : Pharmaceuticals | Published Date : Jan 2025 | Type : Press Release
Closed System Transfer Device Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Closed System Transfer Device (CSTD) Market size was valued at USD 1,485.62 million in 2024 and is projected to grow at a CAGR of 14.4%, reaching USD 4,358.25 million by 2032. CSTDs are specialized devices designed to safely transfer hazardous drugs and other compounds, creating a sealed environment that minimizes contamination and protects healthcare workers. These devices find applications in oncology drug administration, compounding pharmacies, and other healthcare settings requiring safe handling of hazardous substances.
The report comprises the Closed System Transfer Device Market Share, Size & Industry Analysis, based on Type (Membrane-to-Membrane Systems, Needleless Systems), Component (Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, Accessories), Technology (Diaphragm-Based Systems, Compartmentalized Systems, Air Cleaning/Filtration Systems), Application (Chemotherapy Drug Administration, Hazardous Drug Handling, Compounding Procedures, Others), End-Use (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, Others), and Region (North America, Europe, Asia-Pacific, Middle East & Africa, Latin America), and Forecast, 2025-2032.
The report contains detailed information on Closed System Transfer Device Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profiles, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
The rising prevalence of cancer and the associated demand for safe oncology drug handling drive market growth. However, challenges such as high costs and stringent regulatory requirements hinder widespread adoption.
Segmental Analysis :
Based on type, the market is segmented into Membrane-to-Membrane Systems and Needleless Systems.
- The Membrane-to-Membrane Systems segment accounted for the largest revenue share in 2024, driven by its capability to prevent hazardous drug leakage and ensure airtight sealing, particularly for chemotherapy drugs.
- The Needleless Systems segment is anticipated to register the fastest CAGR, supported by its ability to eliminate needle-stick injuries and improve safety during hazardous drug handling.
Based on component, the market is segmented into Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, and Accessories.
- The Vial Access Devices segment held the largest share in 2024, owing to its widespread use in drug preparation and compounding to ensure contamination-free transfer.
- The Syringe Safety Devices segment is projected to grow at the fastest rate, driven by increasing focus on occupational safety and advancements in syringe technologies.
Based on technology, the market is segmented into Diaphragm-Based Systems, Compartmentalized Systems, and Air Cleaning/Filtration Systems.
- The Diaphragm-Based Systems segment dominated the market in 2024, attributed to its reliability in preventing aerosolization and contamination during drug transfers.
- The Air Cleaning/Filtration Systems segment is expected to grow at the fastest CAGR, driven by increasing awareness of healthcare worker safety and regulatory compliance.
Based on application, the market is segmented into Chemotherapy Drug Administration, Hazardous Drug Handling, Compounding Procedures, and Others.
- The Chemotherapy Drug Administration segment accounted for the largest share in 2024, driven by rising global cancer prevalence and increasing cytotoxic drug use.
- The Hazardous Drug Handling segment is expected to grow at the fastest CAGR, supported by increasing adoption in oncology clinics and ambulatory surgical centers.
Based on end-use, the market is segmented into Hospitals, Oncology Clinics, Ambulatory Surgical Centers, and Others.
- The Hospitals segment dominated the market in 2024, driven by the high volume of chemotherapy treatments and stringent safety protocols.
- The Oncology Clinics segment is projected to grow at the fastest rate, supported by expanding outpatient cancer treatment facilities globally.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America: Held a significant market share in 2024, driven by stringent regulatory frameworks and high adoption of CSTDs in the U.S. healthcare sector.
- Asia-Pacific: Expected to grow at the fastest CAGR of 14.9%, fueled by increasing healthcare investments and cancer prevalence in China and India.
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 4,358.25 Million |
| CAGR (2025-2032) | 14.4% |
| Type | Membrane-to-Membrane Systems, Needleless Systems |
| Component | Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices, Accessories |
| Technology | Diaphragm-Based Systems, Compartmentalized Systems, Air Cleaning/Filtration Systems |
| Application | Chemotherapy Drug Administration, Hazardous Drug Handling, Compounding Procedures, Others |
| End-Use | Hospitals, Oncology Clinics, Ambulatory Surgical Centers, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Closed System Transfer Device Industry:
- Becton, Dickinson and Company (BD) (USA)
- ICU Medical, Inc. (USA)
- B. Braun Melsungen AG (Germany)
- Baxter International Inc. (USA)
- Equashield LLC (USA)
- Simplivia Healthcare (Israel)
- Corvida Medical (USA)
- Yukon Medical, LLC (USA)
- Caragen Ltd. (Ireland)
- JMS North America Corporation (USA)
Recent Industry Developments :
- February 2024: NIOSH initiated the development of a unified test protocol for CSTDs, ensuring standardized performance criteria for effective containment of hazardous drugs.
